Zobrazeno 1 - 10
of 695
pro vyhledávání: '"Collignon E"'
Autor:
Collignon E; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Centre (U-CRC) and Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Publikováno v:
Current opinion in oncology [Curr Opin Oncol] 2024 Mar 01; Vol. 36 (2), pp. 74-81. Date of Electronic Publication: 2024 Jan 02.
Autor:
Kim YK; Program in Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto, ON M5G 0A4, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5G 1X5, Canada. Electronic address: yun-kyo.kim@sickkids.ca., Collignon E; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Centre (U-CRC) and Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: evelyne.collignon@ulb.be., Martin SB; Department of Molecular Genetics, University of Toronto, Toronto, ON M5G 1X5, Canada; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5T 3L9, Canada. Electronic address: bmartin@lunenfeld.ca., Ramalho-Santos M; Department of Molecular Genetics, University of Toronto, Toronto, ON M5G 1X5, Canada; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5T 3L9, Canada. Electronic address: mrsantos@lunenfeld.ca.
Publikováno v:
Trends in genetics : TIG [Trends Genet] 2024 Sep 12. Date of Electronic Publication: 2024 Sep 12.
Autor:
Mersiades AJ; National Health & Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Camperdown, NSW, 2050, Australia.; Department of Medical Oncology, Northern Beaches Hospital, Frenchs Forest, NSW, 2086, Australia., Solomon BJ; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, 3001, Australia., Thomas DM; Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia.; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Randwick, NSW, 2031, Australia., Lee CK; National Health & Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Camperdown, NSW, 2050, Australia.; Department of Medical Oncology, St George Hospital, Kogarah, NSW, 2217, Australia., Cummins MM; National Health & Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Camperdown, NSW, 2050, Australia., Sebastian L; National Health & Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Camperdown, NSW, 2050, Australia., Ballinger ML; Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia.; St Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Randwick, NSW, 2031, Australia., Collignon E; Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia., Turnbull OM; Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia., Yip S; National Health & Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Camperdown, NSW, 2050, Australia., Morton RL; National Health & Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Camperdown, NSW, 2050, Australia., Brown C; National Health & Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Camperdown, NSW, 2050, Australia., Wheeler PJ; National Health & Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Camperdown, NSW, 2050, Australia., Itchins M; Department of Medical Oncology, Royal North Shore Hospital, University of Sydney, St Leonards, NSW, 2065, Australia., Simes RJ; National Health & Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Camperdown, NSW, 2050, Australia., Pavlakis N; Department of Medical Oncology, Royal North Shore Hospital, University of Sydney, St Leonards, NSW, 2065, Australia.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Mar; Vol. 20 (7), pp. 361-371. Date of Electronic Publication: 2023 Sep 28.
1513P Impact of symptom and functional burden on survival in pancreatic ductal adenocarcinoma (PDAC)
Autor:
Pitiyarachchi, O., Lin, F.P., Spooner, A., Sharbeen, G., Barker, H.P., Thornton, K., Collignon, E., Ballinger, M.L., Thomas, D.M., Magenau, A., Porazinski, S., Raina, A., Sjoquist, K.M., Chantrill, L.A., Gebski, V., Sowmya, A., Timpson, P., Pajic, M., Goldstein, D., Phillips, P.A.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S925-S925
Autor:
Collignon E; Lunenfeld-Tanenbaum Research Institute and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. evelyne.collignon@ulb.be.; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Centre (U-CRC) and Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. evelyne.collignon@ulb.be., Cho B; Lunenfeld-Tanenbaum Research Institute and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Furlan G; Lunenfeld-Tanenbaum Research Institute and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Fothergill-Robinson J; Lunenfeld-Tanenbaum Research Institute and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Martin SB; Lunenfeld-Tanenbaum Research Institute and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., McClymont SA; Lunenfeld-Tanenbaum Research Institute and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Ross RL; Thermo Fisher Scientific, Franklin, MA, USA., Limbach PA; Rieveschl Laboratories for Mass Spectrometry, Department of Chemistry, University of Cincinnati, Cincinnati, OH, USA., Ramalho-Santos M; Lunenfeld-Tanenbaum Research Institute and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. mrsantos@lunenfeld.ca.
Publikováno v:
Nature cell biology [Nat Cell Biol] 2023 Sep; Vol. 25 (9), pp. 1279-1289. Date of Electronic Publication: 2023 Sep 07.
Autor:
Collignon E; Lunenfeld-Tanenbaum Research Institute and Department of Molecular Genetics, University of Toronto; Toronto, ON M5T 3H7, Canada., Cho B; Lunenfeld-Tanenbaum Research Institute and Department of Molecular Genetics, University of Toronto; Toronto, ON M5T 3H7, Canada., Fothergill-Robinson J; Lunenfeld-Tanenbaum Research Institute and Department of Molecular Genetics, University of Toronto; Toronto, ON M5T 3H7, Canada., Furlan G; Lunenfeld-Tanenbaum Research Institute and Department of Molecular Genetics, University of Toronto; Toronto, ON M5T 3H7, Canada., Ross RL; Thermo Fisher Scientific; Franklin, MA 02038, USA., Limbach PA; Rieveschl Laboratories for Mass Spectrometry, Department of Chemistry, University of Cincinnati; Cincinnati, OH 45221, USA., Ramalho-Santos M; Lunenfeld-Tanenbaum Research Institute and Department of Molecular Genetics, University of Toronto; Toronto, ON M5T 3H7, Canada.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Feb 01. Date of Electronic Publication: 2023 Feb 01.
Autor:
Jeschke J; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Collignon E; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Al Wardi C; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Krayem M; Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, ULB, Brussels, Belgium., Bizet M; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Jia Y; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium.; Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China., Garaud S; Molecular Immunology Laboratory, Institut Jules Bordet, ULB, Brussels, Belgium., Wimana Z; Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, ULB, Brussels, Belgium.; Department of Nuclear Medicine, Institut Jules Bordet, ULB, Brussels, Belgium., Calonne E; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Hassabi B; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Morandini R; Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, ULB, Brussels, Belgium., Deplus R; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Putmans P; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Dube G; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Singh NK; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium., Koch A; Department of Pathology, Maastricht UMC, Maastricht, the Netherlands., Shostak K; Laboratory of Medical Chemistry, GIGA Stem Cells, University of Liège, Liège, Belgium., Rizzotto L; Trace, LKI Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Ross RL; Rieveschl Laboratories for Mass Spectrometry, Department of Chemistry, University of Cincinnati, Cincinnati, OH, USA., Desmedt C; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, U-CRC, ULB, Brussels, Belgium., Bareche Y; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, U-CRC, ULB, Brussels, Belgium., Rothé F; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, U-CRC, ULB, Brussels, Belgium., Lehmann-Che J; Pathophysiology of Breast Cancer Team, Université de Paris, INSERM U976, HIPI, Paris, France.; Breast Disease Unit and Molecular Oncology Unit, AP-HP, Hôpital Saint-Louis, Paris, France., Duterque-Coquillaud M; Université Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-UMR-S 1277, CANTHER, Lille, France., Leroy X; Université Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-UMR-S 1277, CANTHER, Lille, France.; Department of Pathology, CHU Lille, Université Lille, Lille, France., Menschaert G; Biobix, Laboratory of Bioinformatics and Computational Genomics, Ghent University, Ghent, Belgium., Teixeira L; Pathophysiology of Breast Cancer Team, Université de Paris, INSERM U976, HIPI, Paris, France.; Breast Disease Unit and Molecular Oncology Unit, AP-HP, Hôpital Saint-Louis, Paris, France., Guo M; Department of Gastroenterology & Hepatology, Chinese PLA General Hospital, Beijing, China., Limbach PA; Rieveschl Laboratories for Mass Spectrometry, Department of Chemistry, University of Cincinnati, Cincinnati, OH, USA., Close P; Laboratory of Cancer Signaling, GIGA Stem Cells, University of Liège, Liège, Belgium.; WELBIO, University of Liège, Liège, Belgium., Chariot A; Laboratory of Medical Chemistry, GIGA Stem Cells, University of Liège, Liège, Belgium.; WELBIO, University of Liège, Liège, Belgium., Leucci E; Trace, LKI Leuven Cancer Institute, KU Leuven, Leuven, Belgium.; Laboratory of RNA Cancer Biology, Department of Oncology, LKI, KU Leuven, Leuven, Belgium., Ghanem G; Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, ULB, Brussels, Belgium., Yuan BF; College of Chemistry and Molecular Sciences, Wuhan University, Wuhan, China., Willard-Gallo K; Molecular Immunology Laboratory, Institut Jules Bordet, ULB, Brussels, Belgium., Sotiriou C; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, U-CRC, ULB, Brussels, Belgium., Marine JC; Laboratory for Molecular Cancer Biology, VIB, KU Leuven, Leuven, Belgium.; Laboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium., Fuks F; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université Libre de Bruxelles (ULB), Brussels, Belgium. ffuks@ulb.ac.be.; WELBIO, Université Libre de Bruxelles (ULB), Brussels, Belgium. ffuks@ulb.ac.be.
Publikováno v:
Nature cancer [Nat Cancer] 2021 Jun; Vol. 2 (6), pp. 611-628. Date of Electronic Publication: 2021 Jun 23.
Autor:
Gonzalez Agurto, Maria1 (AUTHOR) gcanedo@uandes.cl, Olivares, Nicolas2 (AUTHOR) nholivares@uc.cl, Canedo-Marroquin, Gisela1,2,3 (AUTHOR), Espinoza, Daniela4 (AUTHOR), Tortora, Sofia C.5 (AUTHOR) mgonzaleza@uandes.cl
Publikováno v:
Cancers. Oct2024, Vol. 16 Issue 20, p3545. 23p.
Autor:
Asada, Ken1,2 (AUTHOR) ken.asada@riken.jp, Kaneko, Syuzo1,2 (AUTHOR), Takasawa, Ken1,2 (AUTHOR), Shiraishi, Kouya3 (AUTHOR), Shinkai, Norio1,2 (AUTHOR), Shimada, Yoko3 (AUTHOR), Takahashi, Satoshi1,2 (AUTHOR), Machino, Hidenori1,2 (AUTHOR), Kobayashi, Kazuma1,2 (AUTHOR), Bolatkan, Amina1,2 (AUTHOR), Komatsu, Masaaki1,2 (AUTHOR), Yamada, Masayoshi4 (AUTHOR), Miyake, Mototaka5 (AUTHOR), Watanabe, Hirokazu5 (AUTHOR), Tateishi, Akiko6 (AUTHOR), Mizuno, Takaaki3,6,7 (AUTHOR), Okubo, Yu8 (AUTHOR), Mukai, Masami9 (AUTHOR), Yoshida, Tatsuya6 (AUTHOR), Yoshida, Yukihiro8 (AUTHOR)
Publikováno v:
Molecular Cancer. 9/2/2024, Vol. 23 Issue 1, p1-9. 9p.
Autor:
Rehman SK; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, Canada., Haynes J; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, Canada., Collignon E; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5T 3L9, Canada., Brown KR; Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada., Wang Y; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, Canada., Nixon AML; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada., Bruce JP; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, Canada., Wintersinger JA; Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada; Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada; Department of Computer Science, University of Toronto, Toronto, ON M5T 3A1, Canada; Vector Institute, Toronto, ON M5G 1M1, Canada., Singh Mer A; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada., Lo EBL; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, Canada., Leung C; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, Canada., Lima-Fernandes E; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, Canada., Pedley NM; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, Canada., Soares F; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, Canada., McGibbon S; Department of Physics, University of Toronto, Toronto, ON M5S 1A7, Canada., He HH; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada., Pollet A; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5T 3L9, Canada., Pugh TJ; Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada; Clinical Genomics Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C1, Canada., Haibe-Kains B; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Computer Science, University of Toronto, Toronto, ON M5T 3A1, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada., Morris Q; Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada; Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada; Department of Computer Science, University of Toronto, Toronto, ON M5T 3A1, Canada; Vector Institute, Toronto, ON M5G 1M1, Canada; Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Ramalho-Santos M; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON M5T 3L9, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada. Electronic address: mrsantos@lunenfeld.ca., Goyal S; Department of Physics, University of Toronto, Toronto, ON M5S 1A7, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON M5S 3E1, Canada. Electronic address: goyal@physics.utoronto.ca., Moffat J; Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON M5S 3E1, Canada. Electronic address: j.moffat@utoronto.ca., O'Brien CA; Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 1L7, Canada; Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada; Department of Surgery, University Health Network, Toronto, ON M5G 1L7, Canada. Electronic address: cobrien@uhnresearch.ca.
Publikováno v:
Cell [Cell] 2021 Jan 07; Vol. 184 (1), pp. 226-242.e21.